The ALaCaRT rectal surgery trial was recently selected by the American Society of Clinical Oncology for inclusion in Clinical Cancer Advances 2017, the society’s annual review of progress against cancer and emerging trends in the field.
The study has been featured as one of the year’s major achievements internationally in clinical cancer research and care.
The ALaCaRT trial, a collaboration of the Australasian Gastro-Intestinal Trials Group and the Colorectal Surgical Society of Australia and New Zealand with CTC, was led by Brisbane colorectal surgeon, Dr Andrew Stevenson.
Results of the trial were first published in JAMA in 2015. Click here for more information.